...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis
【24h】

4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis

机译:4-(3-硝基苯基)噻唑-2-基hydr衍生物作为抗氧化剂和选择性hMAO-B抑制剂:合成,生物活性和计算分析

获取原文

摘要

A new series of 4-(3-nitrophenyl)thiazol-2-ylhydrazone derivatives were designed, synthesised, and evaluated to assess their inhibitory effect on the human monoamine oxidase (hMAO) A and B isoforms. Different (un)substituted (hetero)aromatic substituents were linked to N1 of the hydrazone in order to establish robust structure-activity relationships. The results of the biological testing demonstrated that the presence of the hydrazothiazole nucleus bearing at C4 a phenyl ring functionalised at the meta position with a nitro group represents an important pharmacophoric feature to obtain selective and reversible human MAO-B inhibition for the treatment of neurodegenerative disorders. In addition, the most potent and selective MAO-B inhibitors were evaluated in silico as potential cholinesterase (AChE/BuChE) inhibitors and in vitro for antioxidant activities. The results obtained from molecular modelling studies provided insight into the multiple interactions and structural requirements for the reported MAO inhibitory properties.
机译:设计,合成和评估了一系列新的4-(3-硝基苯基)噻唑-2-基hydr衍生物,以评估它们对人单胺氧化酶(hMAO)A和B同工型的抑制作用。为了建立稳固的结构-活性关系,将不同的(未)取代的(杂)芳族取代基连接到N的N1上。生物学测试的结果表明,在C4位带有亚硝基功能化的苯环处带有苯环的hydr噻唑核的存在代表着重要的药效学特征,以获得选择性和可逆的人MAO-B抑制作用来治疗神经退行性疾病。此外,在计算机上评估了最有效和选择性最大的MAO-B抑制剂作为潜在的胆碱酯酶(AChE / BuChE)抑制剂,并在体外评估了其抗氧化活性。从分子建模研究中获得的结果为所报道的MAO抑制特性的多重相互作用和结构要求提供了见识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号